Table 1.
Demographics of MERS positive HCW, MERS positive non-HCW and MERS negative cases.
Table 2.
Comparison of potential exposure factors among the three patient groups.
Table 3.
Comparison of clinical symptoms and co-morbidity status among the three patient groups.
Table 4.
Comparison of laboratory parameters among three patient groups.
Table 5.
Comparison of poor outcome among three patient groups.
Table 6.
Factors associated with poor outcome (admission to ICU or death) among 48 MERS patients.
Table 7.
Factors associated with fatal outcome in 48 MERS cases.
Fig 1.
Time from hospital admission to death.
A: Comparing patients with MERS-CoV infection (red line) and those negative for MERS-CoV (black line) (p = 0.01). B: Comparing health care workers with MERS CoV (red dotted line; group1), non-HCW with MERS (red solid line; group 2) and patients without MERS-CoV infection (black solid line; group 3). Log rank test group 1 vs. group 2 p = 0.003; group 2 vs group 3 p = 0.45; group 1 vs group 3 p<0.001.
Fig 2.
Time from hospital admission to death stratified by comorbid disease status among MERS positive cases.
Survival analysis was carried out to ascertain impact of co-morbidities on survival in patients with MERS-CoV infection. Black line (group 1): No comorbid disease; Red line (group 2): Diabetes with or without other comorbidities; Green line (group 3): Any other comorbid disease without diabetes. Log rank test: group 1 vs group 2 p = 0.01; Group 1 vs. group 3 p = 0.54; group 2 vs. group 3 p = 0.01.